Inventor · disambiguated record
Philip John Hogg
Also filed as: HOGG PHILIP · HOGG PHILIP J · HOGG PHILIP JOHN
11 granted patents·8 pending applications·36 citations·filing 2000–2025
86Inventor score
Files withNEW SOUTH INNOVATIONS PTY LTD6CENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY5NEWSOUTH INNOVATIONS PTY LTD4HOGG PHILIP JOHN2HOGG PHILIP J1
Top patents by PatentIndex Score
19 records- 0180US7186695B2Treatment of arthritis with arsenoxide compoundsNEW SOUTH INNOVATIONS PTY LTD·Filed 2002·Granted Mar 6, 2007·15 cites·22 claims
- 0278US7498406B2Substantially cell membrane impermeable compound and use thereofNEW SOUTH INNOVATIONS PTY LTD·Filed 2006·Granted Mar 3, 2009·5 cites·20 claims
- 0373US12296030B2Conjugates and their use as imaging agentsCENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY·Filed 2023·Granted May 13, 2025·0 cites·19 claims
- 0473US7074766B1Substantially cell membrane impermeable compound and use thereofNEW SOUTH INNOVATIONS PTY LTD·Filed 2000·Granted Jul 11, 2006·9 cites·23 claims
- 0571US8268883B2Organo-arsenoxide compounds and use thereofHOGG PHILIP JOHN·Filed 2007·Granted Sep 18, 2012·3 cites·19 claims
- 0668US7635464B2Selective targeting of apoptotic cellsNEW SOUTH INNOVATIONS PTY LTD·Filed 2002·Granted Dec 22, 2009·4 cites·33 claims
- 0765US2025325716A1Conjugates and their use as imaging agentsCENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY·Filed 2025·Application pending·0 cites
- 0861US11452735B2Pharmaceutical combinations of organo-arsenoxide compounds and mTOR inhibitorsNEWSOUTH INNOVATIONS PTY LTD·Filed 2020·Granted Sep 27, 2022·0 cites·10 claims
- 0957US2009311179A1Selective Targeting of Apoptotic CellsNEW SOUTH INNOVATIONS PTY LTD·Filed 2009·Application pending·0 cites
- 1056US9353152B2Induction of the mitochondrial permeability transitionNEWSOUTH INNOVATIONS PTY LTD·Filed 2013·Granted May 31, 2016·0 cites·2 claims
- 1152US7674775B2Substantially cell membrane impermeable compound and use thereofNEW SOUTH INNOVATIONS PTY LTD·Filed 2006·Granted Mar 9, 2010·0 cites·22 claims
- 1251US2022152229A1Conjugates and their use as imaging agentsCENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY·Filed 2020·Application pending·0 cites
- 1351US2023398240A1Therapeutic radiolabelled conjugates and their use in therapyCENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY·Filed 2023·Application pending·0 cites
- 1449US2025269072A1Processes for preparing radiolabelled conjugatesCENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY·Filed 2022·Application pending·0 cites
- 1548US2006166208A1Induction of the mitochondrial permeability transitionHOGG PHILIP J·Filed 2003·Application pending·0 cites
- 1647US2018140620A1Pharmaceutical Combinations of Organo-Arsenoxide Compounds and mTOR InhibitorsNEWSOUTH INNOVATIONS PTY LTD·Filed 2015·Application pending·0 cites
- 1746US9765101B2Organo-arsenoxide compounds and use thereofHOGG PHILIP JOHN·Filed 2012·Granted Sep 19, 2017·0 cites·22 claims
- 1838US2003040515A1Regulation of platelet adhesion and aggregationFiled 2001·Application pending·0 cites
- 1927US10828275B2Selective targeting of procoagulant plateletsNEWSOUTH INNOVATIONS PTY LTD·Filed 2015·Granted Nov 10, 2020·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Philip John Hogg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →